QHP 2008 / Catechols.DOCS

Created : 27-Mar-09
Last Modified : 27-Mar-09
Author : Tom Coleman
Copyright : 2009

<structurename> NEPool </structurename>

<vardoc>
<name> NEPool.[NE(nMol/L)] </name>
<topic> NE - Overview </topic>
<topic> NE - Physical Units9 </topic>
<topic> NE - Concentration Units10 </topic>
<seealso> AlphaBlockade.Block(%) </seealso>
<seealso> Pheochromocytoma.Change </seealso>
</vardoc>

<vardoc>
<name> NEPool.[NE(pG/mL)] </name>
<topic> NE - Overview </topic>
<topic> NE - Physical Units9 </topic>
<topic> NE - Concentration Units10 </topic>
</vardoc>

<vardoc>
<name> NEPool.[NE]</name>
<topic> NE - Overview </topic>
<topic> NE - Physical Units9 </topic>
<topic> NE - Concentration Units10 </topic>
<seealso> NEPool.Mass </seealso>
<seealso> ECFV.Vol </seealso>
</vardoc>

<vardoc>
<name>  NEPool.Change </name>
<topic> Change - NEPDefinition1 </topic>
<topic> NE - Physical Units9 </topic>
<topic> NE - Concentration Units10 </topic>
<seealso> NEPool.Gain </seealso>
<seealso> NEPool.Loss </seealso>
</vardoc>

<vardoc>
<name> NEPool.F1 </name>
<topic> F1 - NEPDefinition2 </topic>
<topic> NE - Physical Units9 </topic>
<topic> NE - Concentration Units10 </topic>
</vardoc>

<vardoc>
<name> NEPool.F2 </name>
<topic> F2 - NEPDefinition3  </topic>
<topic> NE - Physical Units9 </topic>
<topic> NE - Concentration Units10 </topic>
</vardoc>

<vardoc>
<name> NEPool.Gain </name>
<topic> Gain - NEPDefinition4 </topic>
<seealso> NESecretion.Rate </seealso>
<seealso> NESecretion.Spillover </seealso>
<seealso> NEpump.Rate </seealso>
<seealso> Pheochromocytoma.NERate </seealso>
</vardoc>

<vardoc>
<name> NEPool.InitialMass </name>
<topic> InitialMass - NEPDefinition6 </topic>
<topic> NE - Physical Units </topic>
<topic> NE - Concentration Units </topic>
</vardoc>

<vardoc>
<name> NEPool.Loss </name>
<topic> Loss - NEPDefinition5 </topic>
<seealso> NEClearance.Rate </seealso>
</vardoc>

<vardoc>
<name> NEPool.Mass </name>
<topic> Mass - NEPDefinition7 </topic>
<topic> NE - Overview </topic>
<topic> NE - Physical Units </topic>
<topic> NE - Concentration Units </topic>
<seealso> ECFV.Vol </seealso>
</vardoc>

<vardoc>
<name> NEPool.Target[NE] </name>
<topic> Target[NE] - NEPDefinition8 </topic>
</vardoc>

<topicdoc>
<name> NE - Overview </name>
<label> Overview </label>
<content>

Norepinephrine (NE) is the neurotransmitter released 
from axon terminals of sympathetic postganglionic neurons. 
Norepinephrine is also released from the adrenal medullae 
in response to sympathetic nerve stimulation. 
Under resting conditions, only a few percent of the NE 
entering the plasma represents adrenal medullary secretion. 
The remainder has its source in the neurotransmitter released 
by sympathetic nerve varicosities. This NE is referred to 
as spillover. Total body spillover can be measured using a 
tracer kinetic method based on dilution of [3H]NE by endogenous NE.

Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G.
Overflow of catecholeamine neurotransmitters to the circulation:
Source, fate and Functions. Physiol Rev 70:963-985, 1990

Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance
of plasma levels of catechols and their metabolites in humans.
J Pharmacol Exp Ther 305(3): 800-811, 2003.

NE excites both alpha and beta adrenergic receptors and causes
a range of different effects in different effector organs 
depending on the plasma concentration and the density and types 
of receptors present. In patients with pheochromocytoma, an 
increase in plasma NE causes symptoms which include 
hypertension, severe headaches, palpitations and excess sweating. 
These symptoms reflect the effects of norepinephrine 
on alpha and beta adrenergic receptors respectively.

</content>
</topicdoc>

<topicdoc>
<name> NE - Physical Units9 </name>
<label> Physical Units </label>
<content>

[Plasma]    pG/mL or nMol/L  
pG/mL * 0.00592 = nMol/L
nMol * 0.1692 = ug
Mass nG or pG

milli = 10^-3
micro = 10^-6
nano  = 10^-9
pico  = 10^-12


</content>
</topicdoc>

<topicdoc>
<name> NE - Concentration Units10 </name>
<label> Concentration Units </label>
<content>

Norepinephrine (C8 H11 N O3) has a molecular
weight of 169. Typical plasma concentration of 
NE is 240pG/mL or 1.42nMol/L (Multiply by 0.00592
to convert pG/mL to nMol/L)

The NE Pool or mass is a function of NE Secretion, 
NE Clearance and the volume of distribution. 
Since the volume of distribution for epinephrine is 
the ECFV (15,000 mL), the typical circulating pool
is 3600 nG

</content>
</topicdoc>

<topicdoc>
<name> Change - NEPDefinition1 </name>
<label> Definition </label>
<content>

Changes in the NE pool or mass are a function of both
gains and losses in NE over time. Gains may occur from
increased secretion due to sympathetic nerve stimulation;
from infusion of NE using the NE pump feature of the
model and/or increases from a NE secreting pheochromocytoma.

</content>
</topicdoc> 

<topicdoc>
<name> F1 - NEPDefinition2 </name>
<label> Definition </label>
<content>

F1 is a mathematical variable used in the calculation of
the mass or pool of NE. F1 is the gain in NE over time and
is a function of NE secretion rate, NE spillover rate, NE 
pump rate and pheochromocytoma NE rate

</content>
</topicdoc>


<topicdoc>
<name> F2 - NEPDefinition3 </name>
<label> Definition </label>
<content>

F2 is a mathematical variable used in the calculation of 
the mass of NE. F2 is the loss in NE over time and is
a function of NE clearance rate. 

</content>
</topicdoc>

<topicdoc>
<name> Gain - NEPDefinition4 </name>
<label> Definition </label>
<content>

Gain is defined as positive changes in mass of NE 
and is a function of NE secretion rate, NE spillover,
NE from infusion (using the NE pump feature) and
any NE secretion from a possible pheochromocytoma.
The model user may create a pheochromocytoma and 
define different levels of severity.

</content>
</topicdoc>

<topicdoc>
<name> Loss - NEPDefinition5 </name>
<label> Definition </label>
<content>

Loss is defined as a negative change in mass of NE
and is a function of clearance rate and ECFV.

</content>
</topicdoc>

<topicdoc>
<name> InitialMass - NEPDefinition6 </name>
<label> Definition </label>
<content>

The initial mass is the starting amount of NE.
Since the plasma concentration of NE (the target[NE])is 
240pG/mL and the volume of distribution for epinephrine is 
the ECFV (15,000 mL), the typical initial mass
is 3600 nG (0.24*15,000).

Initial Mass = Target[NE]*ECFV.Vol

</content>
</topicdoc> 

<topicdoc>
<name> Mass - NEPDefinition7 </name>
<label> Definition </label>
<content>

Mass or pool is the calculated amount of circulating
NE. Gains and losses in NE are integrated over time
to calculate the NE Pool or mass.

</content>
</topicdoc>  

<topicdoc>
<name> Target[NE] - NEPDefinition8 </name>
<label> Definition </label>
<content>

The Target[NE] is the starting plasma concentration of
norepinephrine. Under normal physiological
conditions Target[NE] is 240pG/mL

</content>
</topicdoc> 
  
End